Rafael Holdings, Inc. (RFL) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Rafael Holdings, Inc. $0.61, price $2.02, upside -69.7%, quality 39 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Fair value above price? No
- Good quality? No
- Add to watchlist
Rafael Holdings, Inc.
RFL · USWeakest SetupStrongly overvalued and low quality.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
60‑month range $1.16 – $62.71 · fair‑value band $0.4080 – $0.7650 · the $2.02 price screens above the $0.6120 fair value. Dashed = 300-day average. As of Sep 23, 2026.
Every Wednesday you see whether Rafael Holdings is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate.
Show more
Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is Trappsol Cyclo, which is in phase 3 clinical trial being evaluated for the potential treatment of Niemann-Pick Disease Type C1 (NPC1), a rare, fatal and progressive genetic disorder; and CPI-613 (devimistat), a stable analog of normally transient, acylated catalytic intermediates of lipoate, which is in phase II of clinical trial. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1A and 1B clinical studies targeting patients with advanced cancers. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrument for Carpal Tunnel syndrome. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.
Stock analysis
Rafael Holdings, Inc. (RFL) currently trades at $2.02, while our model-based Fair Value estimate is $0.6120, implying the stock looks roughly 230.0% overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 89/100, which puts the evidence level at low.
Scenario range: $0.4080 (bear) to $0.7650 (bull), the price of $2.02 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 39/100 (below-average quality), in the Real Estate sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Rafael Holdings, Inc. reported revenue of $917K in FY2025 versus $802K in FY2021, a compound +3.4%/yr. Reported net income was −$30.5M in FY2025.
Key figures
Market cap $142M · EPS (TTM) $−0.7100 · Return on equity −37.6% · Return on assets (EBIT) −41.8% · Operating margin −3,838% · Revenue (TTM) $980K · Revenue growth (YoY) −50.6% · Free cash flow −$18.9M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (low confidence).
What moves the price
The share trades about 47% below its 52-week high and 74% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Real Estate peers we cover trades at −37% fair-value upside, at −70%, RFL screens richer than that median.
Fair Value models
All 1 models by family
Notify me when RFL reaches fair value
Put RFL on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Quality Score breakdown
Of which business quality 42 · Market factors (momentum, volatility) 57
Revenue & earnings trend
RFL screens 230% overvalued. Compare with Vingroup Joint Stock Company →
Compare Rafael Holdings, Inc. with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Real Estate Services · 547 stocks
Valuation Multiplesvs Real Estate Services median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Real Estate sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Undervalued stocks: Real Estate
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Real Estate Services stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Vingroup Joint Stock Company VIC | 236,000 VND | 25,731 VND | −89% |
| CBRE Group CBRE | $141.05 | $89.43 | −37% |
| Vonovia SE VNA | €17.09 | €36.67 | +115% |
| Cellnex Telecom, S.A CLNX | €25.33 | €23.78 | −6% |
| KE Holdings 2423 | HK$42.78 | HK$17.18 | −60% |
| Jones Lang LaSalle Incorporated JLL | $324.06 | $530.17 | +64% |
| Swire Properties Limited 1972 | HK$24.40 | HK$13.50 | −45% |
| CoStar Group CSGP | $28.77 | $6.17 | −79% |
| China Resources Mixc Lifestyle Services Limited 1209 | HK$37.44 | HK$56.43 | +51% |
| CapitaLand Investment Limited 9CI | 2.62 SGD | 0.5000 SGD | −81% |
Explore undervalued stocks
More undervalued Real Estate stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Rafael Holdings, Inc. (RFL) overvalued or undervalued?
What is the fair value of RFL?
What is the quality score of RFL?
What is the price target for Rafael Holdings, Inc. (RFL)?
What is the Rafael Holdings, Inc. stock forecast for 2026?
What is the revenue of Rafael Holdings, Inc. (RFL)?
What is the intrinsic value of Rafael Holdings, Inc. (RFL)?
Is Rafael Holdings, Inc. stock overvalued or undervalued in 2026?
Is fair value the same as the market price of RFL?
How much is Rafael Holdings, Inc. worth?
What do the bullish and bearish scenarios say about RFL?
How solid is the balance sheet of Rafael Holdings, Inc. (RFL)?
How far is RFL from its 52-week high?
Which stocks are comparable to Rafael Holdings, Inc.?
Is Rafael Holdings, Inc. stock attractive at the current price?
How is the fair value of RFL calculated?
Is it still worth investing in stocks now?
What is the share price of Rafael Holdings, Inc. (RFL)?
What should I pay attention to with Rafael Holdings, Inc. right now?
Key figures of Rafael Holdings, Inc.
How large is the market capitalisation of Rafael Holdings, Inc. (RFL)?
What are the earnings per share of Rafael Holdings, Inc. (RFL)?
What is the return on equity of Rafael Holdings, Inc. (RFL)?
What is the EBIT return on assets of Rafael Holdings, Inc. (RFL)?
What is the operating margin of Rafael Holdings, Inc. (RFL)?
How fast is revenue growing at Rafael Holdings, Inc. (RFL)?
How much free cash flow does Rafael Holdings, Inc. (RFL) generate?
How much net cash does Rafael Holdings, Inc. (RFL) hold?
Watch Rafael Holdings, Inc. in the live analysis
One click puts Rafael Holdings, Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.